FREQUENCY OF AND RISK FACTORS FOR DEVELOPMENT OF ACUTE LUNG INJURY IN PATIENTS ADMITTED WITH SEPTIC SHOCK IN CRITICAL CARE UNIT OF CMH BAHAWALPUR
Main Article Content
Abstract
Objective:
The objective of this study is to observe frequency and risk factors of acute lung injury in patients with septic shock in critical care unit of a tertiary care hospital
Study design:
Cross-sectional Observational study.
Place and duration of study:
Department of Medicine, CMH Bahawalpur, from December 2024-May 2025
Methodology:
A total of 100 patients aged 16–75 years with septic shock were included using non-probability consecutive sampling. Patients with chronic lung diseases, malignancy, corticosteroid use, or pregnancy were excluded. Data were collected through a structured proforma, including demographics, clinical features, and risk factors. Acute lung injury (ALI) was diagnosed based on hypoxemia and radiological findings. Patients were divided into ALI and non-ALI groups. Data were analyzed using SPSS v25, with frequencies, percentages, and odds ratios calculated to assess associations.
Results:
Out of 100 patients, 46% developed acute lung injury. The mean age was 52.4 ± 14.8 years, with male predominance (60%). Delayed antibiotics (42%) and delayed resuscitation (38%) were common risk factors. Strong associations with ALI were observed for high respiratory rate (OR=4.80), delayed resuscitation (OR=4.20), and delayed antibiotics (OR=3.75). Blood transfusion and alcohol use showed moderate associations, while diabetes mellitus had a protective effect. ALI was more frequent among older patients, smokers, and those with prolonged septic shock, indicating both demographic and clinical influences.
Conclusion:
Acute lung injury is a frequent complication of septic shock. Delayed management and high respiratory rate are key predictors. Early intervention and strict adherence to sepsis protocols can reduce risk.
Downloads
Article Details
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.